Socio-Economic Inequalities in Survival of Patients with Prostate Cancer: Role of Age and Gleason Grade at Diagnosis
Open Access
- 13 February 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (2) , e56184
Abstract
In the United Kingdom, survival of prostate cancer patients has improved since the 1990s. A deprivation gap in survival (better survival for the least deprived compared with the most deprived) has been reported but it is not known if differential distribution of earlier age or lower grade disease at diagnosis might explain such patterns. We therefore investigated the impact of age and Gleason grade at diagnosis on the deprivation gap in survival of prostate cancer patients over time. Incident cases of prostate cancer (ICD-10 C61) from the West of Scotland were extracted from the Scottish Cancer Registry from 1991 to 2007. Socio-economic circumstances were measured using the Scottish Index for Multiple Deprivation 2004 (SIMD). Age and deprivation specific mortality rates were obtained from the General Registrar Office for Scotland (GRO(S)). The survival gradient across the five deprivation categories was estimated with linear regression, weighted by the variance of the relative survival estimate. We examined the data for 15,292 adults diagnosed with prostate cancer between 1991 and 2007. Despite substantial improvements in survival of prostate cancer patients, a deprivation gap persists throughout the three periods of diagnoses. The deprivation gap in five year relative survival widened from −4.76 in 1991–1996 to −10.08 in 2003–2007. On age and grade-specific analyses, a significant deprivation gap in five year survival existed between all age groups except among patients' age ≥75 and both low and high grade disease. On multivariate analyses, deprivation was significantly associated with increased excess risk of death (RER 1.48, 95% CI 1.31–1.68, p-value<0.001) independent of age, Gleason grade and period of diagnosis. The deprivation gap in survival from prostate cancer cannot be wholly explained by socio-economic differentials in early detection of disease. Further research is needed to understand whether differences in comorbidities or treatment explain inequalities in prostate cancer outcomes.Keywords
This publication has 28 references indexed in Scilit:
- Racial/ethnic disparities in survival among men diagnosed with prostate cancer in TexasCancer, 2010
- Socioeconomic inequalities in cancer survival in England after the NHS cancer planBritish Journal of Cancer, 2010
- Interplay of Race, Socioeconomic Status, and Treatment on Survival of Patients With Prostate CancerUrology, 2009
- Clinical presentation and initial management of Black men and White men with prostate cancer in the United Kingdom: the PROCESS cohort studyBritish Journal of Cancer, 2009
- Trends in non-metastatic prostate cancer management in the Northern and Yorkshire region of England, 2000–2006British Journal of Cancer, 2009
- Treatment and survival outcomes in young men diagnosed with prostate cancerCancer, 2009
- Survival from prostate cancer in England and Wales up to 2001British Journal of Cancer, 2008
- Cancer survival in England and Wales at the end of the 20th centuryBritish Journal of Cancer, 2008
- Socioeconomic inequalities in cancer survival in Scotland 1986–2000British Journal of Cancer, 2007
- Partial residuals for the proportional hazards regression modelBiometrika, 1982